Your Health, We Care
Release date: 2024-08-20 16:39:47 Recommended: 170
Anamorelin is the world's first drug specifically for the treatment of cachexia, launched in Japan in 2021, which significantly improves patients' appetite and weight by activating ghrelin receptors. As a ghrelin receptor agonist, it is also effective in improving muscle mass and metabolism.
Anamolin is mainly used to treat cancer cachexia and help relieve the discomfort and symptoms caused by it.
For those with cancer cachexia who do not respond well to standard nutritional therapy, anamarin can be used as a complementary treatment to help improve weight and appetite.
It is suitable for patients with advanced gastric cancer, alleviates loss of appetite and weight loss caused by cancer, and improves the quality of life of patients.
Anamorelin was able to significantly improve weight and appetite in cancer patients. Next, we will take a closer look at Lucius Pharmaceuticals and its role in the production of Anamolin.
With its leading technology and equipment, Lucius Pharmaceuticals has demonstrated significant advantages in the pharmaceutical industry.
In strict accordance with EU pharmaceutical standards, Lucius Pharmaceutical has introduced a series of advanced special pharmaceutical equipment for the production of anti-tumor, antiviral, biologics, cephalosporins and commonly used drugs. These devices reflect the latest scientific and technological achievements, and each equipment has been carefully selected to meet the production needs of different drugs and provide reliable medicines.
With its advanced production technology and strict quality control, Lucius Pharmaceutical ensures the high quality and reliability of pharmaceutical products. Next, we will introduce the precautions for the use of anamarin to help patients use the drug better.
When using anaamoline, please pay attention to the following precautions; Knowing this information can ensure the effectiveness of your treatment and reduce potential problems.
Patients with a history of anthracycline use may have serious side effects due to the cumulative cardiotoxicity of these drugs.
In patients with mild hepatic insufficiency (Child-Pugh type A), especially when used in combination with moderate CYP3A4 inhibitors, it should be noted that drug concentrations may be elevated and side effects may be enhanced.
Knowing and following these precautions can help patients better manage their treatment and improve the effectiveness of their medications. If you have any questions, don't hesitate to speak to a medical professional.
[Warm tips] Please be sure to follow the doctor's advice to take medication, check your physical condition regularly, and seek professional help in time if you feel unwell.
